Mitochondrial peptide
Elamipretide
SS-31; MTP-131; Forzinity
Elamipretide is a mitochondria-targeting tetrapeptide that received accelerated U.S. approval in 2025 for a specific rare disease.
- Regulatory status
- Specifically approved in the U.S.
- Scientifically reviewed
- 01.08.2026